MEDISYS Plc.

That was a better post Farty.I expected a summarised argument mind not a verbatum regurgitation of results.As I said in my earlier post Stada and Piramel with combined sales of £1.5m arent going to save mdy.Liberty sales although better than last year arent either.The 3 life savers from mdy are 1. a massive increase in sales in the LTC sector.OR 2.massive increased margins in LTC sector.OR 3. Menarini launch and sell massive amounts.This was all said in my earlier post and all your post added was sales from Target (which I also doubt will save mdy).My conclusion is that we wont know for certain mdy will make it untill we hear of Menarini sales in maybe 6/9 months time.In the meantime funds raised via headstart will drag the share price lower in my opinion.I wont be buying yet.I do admit that from mid January onwards we could hear of Apex winning the Roche case and get a spike up though (but from what low point and exactly when who knows?)